DCAT Week 2023 was our best one yet. Thanks to everyone that made our launch party in the Rainbow Room a truly unforgettable evening. If you couldn’t make it, experience some of the fun in our recap video.
Discover our state-of-the-art 40,000 sq. ft. biomanufacturing facility in San Antonio, Texas. Featuring GCP, GLP, and GMP biomanufacturing in both mammalian and microbial modalities, Scorpius rapidly advances your large molecule projects.
Identify the Right CDMO Partner
When choosing a CDMO partner, the size and stage of your program play an important role in consideration. Hear from Steven Lavezoli, Regional VP of Business Development, about how Scorpius’ flexible, boutique offering is ideally suited to a variety of biologics programs — from early-stage emerging innovators through Big Pharma.
Always a Warm Welcome. It’s the Texas in Us.
The Scorpius team talks about how working within Texas’ friendly culture has helped them take a collaborative approach to CDMO services and biomanufacturing partnerships.
Flexibile end-to-end CDMO solutions
Brian O’Mara, Senior Director, Manufacturing Science & Technology, outlines how Scorpius’ flexible approach to facility design can deliver unparalleled quality, speed, and efficiency to clients’ biomanufacturing projects.
It's never too early for innovators to meet with a CDMO
Our team is ready, willing, and able to bring your project to life. Brian O’Mara, Senior Director, Manufacturing Science & Technology, discusses how effective, early communication between innovators and their outsourcing partner can make a critical difference in a program’s success.
Scorpius' flexible facility and technologies advance client programs quickly
Our multi-product, multi-use San Antonio biomanufacturing facility was carefully designed for flexibility, optimized processes, and seamless tech transfer to GMP commercial manufacturing.
Scorpius' adherence to phase-appropriate cGMPs
Our team leveraged decades of combined industry expertise to offer you the most optimal path from discovery to the clinic and beyond. Mike Fiske, VP of Manufacturing Sciences, explains how we employ phase-appropriate cGMPs to achieve this.
Scorpius' integrated process and analytical expertise translates to speed for your project
Our integrated suite comprises process and analytical development, manufacturing, and testing was designed with clients in mind. Let us streamline your project.
Scorpius' MSAT leadership team: Meet Brian and Mike
Meet Mike Fiske, VP of Manufacturing Sciences, and Brian O’Mara, Senior Director of Manufacturing Science & Technology. Brian and Mike met over 20 years ago developing vaccines and have reunited to form part of Scorpius’ world-class team of biotech veterans.
How does Scorpius ensure manufacturing quality and safety?
Safety and contamination control are paramount to quality biomanufacturing. Hear more from Mike Fiske, VP of Manufacturing Sciences, about what our team has built into our San Antonio facility to ensure project quality and safety.
How is Scorpius moving toward Biopharma 4.0?
The Biopharma 4.0 model is slated to deliver revolutionary automation for biopharmaceutical manufacturing. Hear more from Mike Fiske, VP of Manufacturing Sciences, about what the future might have in store.
What does Scorpius envision for the future of biomanufacturing?
There’s never been a more exciting time to be in the life sciences. Hear more from Mike Fiske, VP of Manufacturing Sciences, about the improvements that today’s tech has brought to our industry, as well as what he foresees for the future of biomanufacturing.
Why did Scorpius decide to build a flexible, multi-use facility?
Flexibility is an outsourcing partner’s biggest strength. Hear more from Mike Fiske, VP of Manufacturing Sciences, about Scorpius’ commitment to designing multi-purpose facilities for manufacturing a wide range of modalities and treatments.
Mammalian and Microbial Expertise. Excellence Defines Us.
Explore the ways in which Scorpius’ facilities are equipped for flexible, multi-use cGMP biomanufacturing that covers both mammalian and microbial-based products on one campus.
Flexibility for Every Product. Customize With Us.
Learn how Scorpius’ agile approach to biomanufacturing a variety of therapeutics in a modular facility prioritizes client-focused programs and services.
Purpose-Built Biomanufacturing. Capacity Within Us.
Learn more about the capacity of Scorpius’ biomanufacturing campus in San Antonio as well as the capabilities and equipment available to customers at this new, state-of-the-art facility.
Mike Fiske on the Importance of In-House Analytics
Mike Fiske, Vice President of Manufacturing Sciences, discusses the importance of integrated analytics and how Scorpius’ in-house bioanalytical capabilities can deliver reduced risk and shorter development timelines to our biomanufacturing clients.
Industry Leaders and Familiar Faces. You Know Us.
Interim Chief Commercial Officer Michelle Calhoun explains how Scorpius creates a uniquely boutique CDMO experience driven by its passionate team of scientific experts.
American Facility and Supply Chain. Security in Us.
The Scorpius team addresses the benefits of working with a domestic CDMO and explains how Scorpius’ commitment to using USA-made equipment and consumables makes it a uniquely American organization.
Get to Know Us: Yamiha Pulliza, Director of Quality Assurance
Become familiar with the team you’ll be working with at Scorpius BioManufacturing by watching this video of Yamiha Pulliza, the Director of Quality Assurance, as she talks about living and working in San Antonio.
Get to Know Us: Mike Fiske, Vice President of Manufacturing Services
Watch this employee spotlight of Mike Fiske, Vice President of Manufacturing Services at Scorpius BioManufacturing, and learn his perspective on biopharma 4.0 and the potential for the future of the industry.